What Will Redefine Pathology in 2026?
January 14, 2026
-
7 min
5 Key Takeaways
-
1
2026 to see rise in AI in R&D.
-
2
Long-read sequencing vital for genetic conditions.
-
3
Digital twins move into routine use in clinical trials.
-
4
Unified AI expected to enhance research capabilities.
-
5
Cultural shift towards inclusive genomics in various nations.
In 2026, advancements in pathology and laboratory medicine promise to reshape the field. Key predictions include the rise of creative AI in R&D, enhanced long-read sequencing for genetic disorders like Huntington's disease, and increased investment in population-specific genomics. The integration of AI for disease target identification and biological modeling will streamline research processes. Digital twins are expected to gain traction in clinical trials, supported by evolving regulatory frameworks. Unified AI in R&D will replace siloed systems, ultimately improving diagnostic accuracy and efficiency.
Listen Tab content
